LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway

被引：0
|
作者：
Jianxin Lv
Wei Yu
Yanan Zhang
Xinhua Cao
Lifei Han
Haolin Hu
Chenfei Wang
机构：
[1] Southeast University,Breast Disease Center, Zhongda Hospital, School of Medicine
[2] China Pharmaceutical University,Jiangsu Key Laboratory of Drug Screening
来源：
Cancer Cell International | / 20卷
关键词：
LNK; Triple-negative breast cancer; p-ERK; JAK/STAT3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway
    Lv, Jianxin
    Yu, Wei
    Zhang, Yanan
    Cao, Xinhua
    Han, Lifei
    Hu, Haolin
    Wang, Chenfei
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [2] MYCL promotes the progression of triple-negative breast cancer by activating the JAK/STAT3 pathway
    Jiang, Hongnan
    Li, Xiaojun
    Wang, Wei
    Hu, Yaofeng
    Ren, Dongliang
    ONCOLOGY REPORTS, 2022, 48 (05)
  • [3] Leptin stimulates the growth of cholangiocarcinoma cells by modulation of the JAK/STAT3/ERK1/2 pathway
    Fava, Giammarco
    Alpini, Gianfranco
    Rychlicki, Chiara
    Svegliati-Baroni, Gianluca
    Trozzi, Luciano
    Saccomanno, Stefania
    di Sario, Antonio
    Marzioni, Marco
    De Morrow, Sharon
    Francis, Heather
    Venter, Julie
    Glaser, Shannon
    Benedetti, Antonio
    HEPATOLOGY, 2006, 44 (04) : 390A - 390A
  • [4] EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling
    Song, Xiang
    Liu, Zhaoyun
    Yu, Zhiyong
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 703 - 717
  • [5] CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway
    Jiang, Xiao
    Huang, Zhijie
    Sun, Xiang
    Zheng, Xianghuai
    Liu, Jingpeng
    Shen, Jun
    Jia, Bo
    Luo, Haiyun
    Mai, Zhaoyi
    Chen, Guodong
    Zhao, Jianjiang
    BMC CANCER, 2020, 20 (01)
  • [6] CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway
    Xiao Jiang
    Zhijie Huang
    Xiang Sun
    Xianghuai Zheng
    Jingpeng Liu
    Jun Shen
    Bo Jia
    Haiyun Luo
    Zhaoyi Mai
    Guodong Chen
    Jianjiang Zhao
    BMC Cancer, 20
  • [7] Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway
    Fang, Zhiqing
    Tang, Yueqing
    Fang, Juanjuan
    Zhou, Zunlin
    Xing, Zhaoquan
    Guo, Zhaoxin
    Guo, Xiaoyu
    Wang, Weichang
    Jiao, Wei
    Xu, Zhonghua
    Liu, Zhaoxu
    PLOS ONE, 2013, 8 (05):
  • [8] IL-9 PROMOTES THE GROWTH OF PANCREATIC CANCER CELLS BY ACTIVATING THE JAK/STAT3 PATHWAY
    Hou, Jian
    Liu, Hailong
    Zhang, Qi
    ACTA MEDICA MEDITERRANEA, 2021, 37 (06): : 3357 - 3362
  • [9] The Effect of Paclitaxel with a STAT3 Pathway Inhibitor on Metastasis in the Treatment of Triple Negative Breast Cancer
    Dincsoy, Adnan Berk
    Gedikli, Esra
    Ozturk, Suleyman Can
    Nikshiqi, Erblina
    Baris, Veysel Ozgur
    Karakoc, Elif
    Muftuoglu, Sevda
    Esendagli, Gunes
    Erdem, Aysen
    ACTA PHYSIOLOGICA, 2023, 240 : 45 - 45
  • [10] Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis
    Renxu Chang
    Lele Song
    Yi Xu
    Yanjun Wu
    Cheng Dai
    Xinyu Wang
    Xia Sun
    Yingyong Hou
    Wei Li
    Xianbao Zhan
    Lixing Zhan
    Nature Communications, 9
12345